Renal tight junction proteins are decreased in cisplatin-induced nephrotoxicity in rats

Joyce Trujillo1, Eduardo Molina-Jijón, Omar Noel Medina-Campos

  • 1Department of Biology, Faculty of Chemistry, National Autonomous University of Mexico (UNAM) , University City, Mexico D.F. , Mexico .

Abstract

Insights

Cisplatin (CP) causes kidney damage by altering tight junction proteins, occludin and claudin-2, linked to oxidative stress. This study investigates these CP-induced nephrotoxicity effects in rats.

Area of Science:

  • Nephrology
  • Biochemistry
  • Cell Biology

Background:

  • Cisplatin (CP) is a widely used chemotherapy agent.
  • CP is known to induce significant nephrotoxicity and oxidative stress.
  • The impact of CP on renal tight junction (TJ) proteins remains largely uncharacterized.

Purpose of the Study:

  • To investigate the alterations in the expression and localization of key TJ proteins (occludin, claudin-2, claudin-5, ZO-1) in rat kidneys following CP administration.
  • To correlate these changes with markers of nephrotoxicity, oxidative stress, and nitrosative stress.

Main Methods:

  • Male Wistar rats were administered a single dose of CP (7.5 mg/kg) or saline.
  • Renal function was assessed using plasma and urinary biomarkers.
  • Histopathology, oxidative/nitrosative stress markers, and TJ protein levels (occludin, claudin-2, claudin-5, ZO-1) were evaluated via Western blot.

Main Results:

  • CP induced significant nephrotoxicity, evidenced by histological damage and altered kidney injury biomarkers.
  • Oxidative and nitrosative stress markers were elevated in CP-treated rats.
  • A significant decrease in the renal expression of occludin and claudin-2 was observed in the CP group.

Conclusions:

  • CP-induced nephrotoxicity in rats is associated with significant alterations in TJ protein expression, specifically a decrease in occludin and claudin-2.
  • These changes in the proximal tubule are linked to the observed oxidative and nitrosative stress.
  • Understanding these mechanisms may offer targets for mitigating CP-induced kidney damage.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.2K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
557
Tight Junctions01:29

Tight Junctions

Tight junctions are molecular seals between cells that prevent the leaking of fluids, ions, and other small solutes across cavities and compartments in multicellular organisms. They are mainly composed of claudin and occludin transmembrane proteins, and other proteins such as tricellulin and JAM (junctional adhesion molecule). All these proteins are 4-pass transmembrane proteins, except JAM, which is a single-pass transmembrane protein belonging to the immunoglobulin superfamily. The...
6.8K
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
1.2K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
816